Influence of antithyroid medication on effective half-life and uptake of 131I following radioiodine therapy;Einfluss von thyreostatischer Medikation auf die effektive Halbwertszeit und den Uptake von 131Iod wahrend einer Radioiodtherapie

NuklearMedizin

Volumn 36, Issue 3, 1997, Pages 87-92

  Moka, D ^a   Voth, E ^a   Schicha, H ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Klin und Poliklin F Nuklearmed   (Germany)

Author keywords

antithyroid medication; effective half life for 131I; hyperthyroidism; radioiodine therapy; uptake of 131I

Indexed keywords

CARBIMAZOLE; IODINE 131; PROPYLTHIOURACIL; THIAMAZOLE;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; THYROTOXICOSIS;

EID: 0030935006     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629866     Document Type: Article

References (22)

1. Becker D, Hurley J. Radioiodine treatment of hyperthyroidism. In: Gottschalk A, Hoffer P, Potchen E, Berger H (eds). Diagnostic Nuclear Medicine. Williams & Wilkins, Baltimore, MD 1988; 778-92.
2. Berg GEB, Michanek AMK, Holmberg ECV, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996; 37: 228-32.
3. Blomfield GW, Jones JC, MacGregor AG, Miller H, Wayne EJ, Weetch RS. Treatment of thyreotoxicosis with radioactive iodine - review of 140 cases. Br Med J 1955; 2: 1223-9.
4. Clerc J, Izembart M, Dagousset F, Heshmati J-P JHM, Chelvalier A, Leger A F, Barritault L. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole. J Nucl Med 1993; 34: 387-93.
5. 131I) therapy. Eur J Nucl Med 1984; 9: 464-6.
6. Cooper D. Treatment of thyreotoxicoxis. In: Braverman L, Utiger R (eds). The Thyroid: A Fundamental and Clinical Text. JB Lippincott. Philadelphia 1991; 887-916.
7. Dressier J. Nuklearmedizinische Therapie 1988: Daten und Fakten. Der Nuklearmediziner 1990; 5/13: 281-7.
8. Giambarresi L, Jacobs A. Radioprotectants. In: Conklin J, Walker R (eds). Military Radiobiology. Academic Press, Orando, FL. 1987; 265-301.
9. Gimlette TMD, Kocak R, Herbert RG, Squire CR. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid. Nuklearmedizin 1981; 20: 72-5.
10. Goolden A, Fraser R. Treatment of thyrotoxicosis with low doses of radioactive iodine. Br Med J 1969; 3: 442-3.
11. Grayson RR. Factors which influence the radioactive iodine thyroidal uptake test. Am J Med 1960; 28: 397-415.
12. Holm LE, Lundell G, Israelsson A, Dahlqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism J Nucl Med 1982; 23: 103-7.
13. Kung AW-C, Yau C-C, Cheng AC-K. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism. Thyroid 1995; 5: 7-12.
14. Marocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 1990; 13: 513-20.
15. McDermott MT, Kidd GS, Dodson LE, Hofeldt FD. Radioiodine-induced thyroid strom. Case report and literature review. Am J Med 1983; 75: 353-9.
16. Nüchel C, Boddenberg B, Schicha H. Die Bedeutung des Radiojodtests für die Berechnung der Therapiedosis bei benignen Schilddrüsenerkrankungen. Nuklearmedizin 1993; 32: 91-98.
17. Reynolds LR, Kotchen TA. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 1979; 139 (6): 651-3.
18. Schicha H, Scheidhauer, K. Radiojodtherapie in Europa - eine Umfrage. Nuklearmedizin 1993; 32: 321-4.
19. 131I and antithyroid drugs' A prospective study. J. Nucl. Med. 1979; 20: 1263-7.
20. Sundram FX. Radioiodine (I-131) uptakes and hormonal (T4) levels in hyperthyroid patients receiving radioiodine therapy while on anti-thyroid drugs and relation to incidence of hypothyroidism at one year. Ann Acad Med 1986; 15/4: 516-20.
21. Tuttle RM, Patience T, Budd S. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995; 5: 243-7.
22. Velkeniers B, Vanhaelst L, Cytryn R, Jonckheer, M. H. Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1988; 8: 1127-9.